WO2006013954A1 - 膨潤可能な水溶性多糖類からなる膨潤剤が含まれた組成物、並びにその組成物が含まれた食品、肥満防止剤及び便秘改善剤 - Google Patents
膨潤可能な水溶性多糖類からなる膨潤剤が含まれた組成物、並びにその組成物が含まれた食品、肥満防止剤及び便秘改善剤 Download PDFInfo
- Publication number
- WO2006013954A1 WO2006013954A1 PCT/JP2005/014383 JP2005014383W WO2006013954A1 WO 2006013954 A1 WO2006013954 A1 WO 2006013954A1 JP 2005014383 W JP2005014383 W JP 2005014383W WO 2006013954 A1 WO2006013954 A1 WO 2006013954A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- swelling
- composition
- constipation
- agent
- water
- Prior art date
Links
- 230000008961 swelling Effects 0.000 title claims abstract description 64
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 206010010774 Constipation Diseases 0.000 title claims abstract description 27
- 235000013305 food Nutrition 0.000 title claims abstract description 17
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 13
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 13
- 150000004676 glycans Chemical class 0.000 title claims abstract 3
- 208000008589 Obesity Diseases 0.000 title abstract description 15
- 235000020824 obesity Nutrition 0.000 title abstract description 15
- 230000003449 preventive effect Effects 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000003112 inhibitor Substances 0.000 claims abstract description 13
- 239000000883 anti-obesity agent Substances 0.000 claims description 6
- 229940125710 antiobesity agent Drugs 0.000 claims description 6
- 229940000425 combination drug Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 abstract description 9
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 238000001035 drying Methods 0.000 abstract description 5
- 239000012456 homogeneous solution Substances 0.000 abstract 1
- 229920000591 gum Polymers 0.000 description 10
- 150000004804 polysaccharides Chemical class 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 239000008141 laxative Substances 0.000 description 7
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 235000010443 alginic acid Nutrition 0.000 description 5
- 229920000615 alginic acid Polymers 0.000 description 5
- 235000013325 dietary fiber Nutrition 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 229920000057 Mannan Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940125722 laxative agent Drugs 0.000 description 4
- 244000247812 Amorphophallus rivieri Species 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 229920002752 Konjac Polymers 0.000 description 3
- 229920001100 Polydextrose Polymers 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229940025902 konjac mannan Drugs 0.000 description 3
- 230000002475 laxative effect Effects 0.000 description 3
- 235000013856 polydextrose Nutrition 0.000 description 3
- 239000001259 polydextrose Substances 0.000 description 3
- 229940035035 polydextrose Drugs 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940124513 senna glycoside Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 241000735631 Senna pendula Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- UJIDKYTZIQTXPM-UHFFFAOYSA-N [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate Chemical compound C1=CC(OS(=O)(=O)O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS(O)(=O)=O)C=C1 UJIDKYTZIQTXPM-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960000503 bisacodyl Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 235000012254 magnesium hydroxide Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930186851 sennoside Natural products 0.000 description 1
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000021076 total caloric intake Nutrition 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/12—Agar or agar-agar, i.e. mixture of agarose and agaropectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
Definitions
- composition comprising a swelling agent comprising a swellable water-soluble polysaccharide, and food, anti-obesity agent and constipation-improving agent comprising the composition
- the present invention relates to a composition
- a composition comprising a pharmacopoeia first liquid or pharmacopoeia second liquid and a swelling agent capable of swelling in water and a water-soluble polysaccharide, and a food containing the composition, obesity
- the present invention relates to an inhibitor and a constipation improving agent.
- Constipation causes abdominal tension and food stays longer in the intestine, causing excessive absorption of sugars and lipids, leading to obesity. Constipation also promotes the production of carcinogens by bad bacteria in the intestine and increases the risk of colorectal cancer. In order to improve this, it is recommended to take the sixth nutrient and dietary fiber! Ingestion of food fiber absorbs water and increases stool volume, shortening gastrointestinal transit time and relieving constipation It can be turned off to prevent colorectal cancer.
- Patent Document 1 describes a dietary fiber-containing composition consisting of alginic acid and polydextrose
- Patent Document 2 describes a constipation-improving agent comprising water-soluble food fiber and sugar alcohol as active ingredients
- Patent Document 3 describes a constipation improving agent containing water-soluble dietary fiber, insoluble fiber, and vegetable juice as active ingredients.
- Patent Document 1 Japanese Patent Laid-Open No. 11 75777
- Patent Document 2 Japanese Patent Laid-Open No. 2000-60487
- Patent Document 3 Japanese Unexamined Patent Publication No. 2003-12537
- Polydextrose, indigestible dextrin, and low-molecular alginic acid that are ingested for the purpose of improving constipation are low-viscosity aqueous solutions, and cellulose such as wheat bran has a low water absorption, so these Does not function well to increase stool volume by taking dietary fiber.
- taking laxatives for the purpose of improving constipation may loosen the stool and cause diarrhea, which places a heavy burden on the user.
- the present invention provides a composition containing a swelling agent that controls swelling and less burdens the stomach or intestine even if it is excessively ingested, and a food containing the composition
- An object of the present invention is to provide an anti-obesity agent and an agent for improving constipation.
- a swelling agent having a water-soluble polysaccharide strength capable of swelling in a pharmacopoeia first liquid or a pharmacopoeia second liquid and water.
- the swelling inhibitor which controls the swelling of the swelling agent, is mixed in a solution state, homogenized and then dried, thereby controlling the swelling and reducing the burden on the stomach and intestine even if it is ingested excessively. I found out.
- the present invention provides a swelling agent comprising a water-soluble polysaccharide that can swell in a pharmacopoeia first liquid or a pharmacopoeia second liquid and water, and a swelling inhibitor that controls the swelling of the swelling agent. It is a composition which is mixed and homogenized and then dried.
- the swelling agent is a water-soluble polysaccharide that dissolves and retains water while absorbing water and swells at an in vivo temperature, and exhibits viscosity. Is a component that dissolves above the in-vivo temperature, but does not dissolve at the in-vivo temperature and has limited water absorption.
- the mixed state at the molecular level mentioned above is
- the swelling inhibitor was heated once to a melting temperature equal to or higher than the in-vivo temperature and dissolved, and further mixed with the swelling agent dissolved in the in-vivo temperature and mixed with each other. It is made by creating a state and then dehydrating.
- the present invention is a food containing such a composition, and further an anti-obesity agent and a constipation improving agent comprising such a composition as a main component. Power! It is also effective to add laxatives to these constipation-improving agents.
- the constipation improving agent according to the present invention is added to the laxative, the mud stool softened by the laxative is increased in stool volume by the constipation improving agent and becomes a smooth loose stool state. This reduces the burden on constipation and increases the quality of life.
- a composition containing a swelling agent that does not give a burden to the stomach or intestine even if excessively consumed, a food containing the composition, and prevention of obesity Agents and constipation-improving agents can be provided.
- the swelling inhibitor suppresses swelling of the swelling agent by gelling.
- a gelling agent that is preferably configured to be at least one of agar, carrageenan, ferceleran, dielan gum, alginic acid and alginate is preferred.
- the swelling inhibitor is preferably adjusted so that the swelling of the swelling agent is controlled within 150 times, preferably within 80 times.
- the swelling agent is silium seed gum, konjac mannan (Dalcomannan), xanthan gum, tamarind gum. , Cellulose derivative, tara gum and guar gum.
- the mixing ratio of the swelling agent and the swelling inhibitor is preferably from 95: 5 to LO: 90. 90:
- the laxative used in combination with the constipation according to the present invention includes salt laxatives such as magnesium oxide, magnesium citrate, magnesium carbonate, sodium sulfate, magnesium sulfate, and magnesium hydroxide, bisacodyl, and picosulfate.
- salt laxatives such as magnesium oxide, magnesium citrate, magnesium carbonate, sodium sulfate, magnesium sulfate, and magnesium hydroxide, bisacodyl, and picosulfate.
- irritant laxatives such as sodium, sennoside, senna, dio, glycerin, aloe, D-sorbitol.
- agar Ina Food Industry Co., Ltd., Ina Agar S-8
- Silium seed gum Dainippon Pharmaceutical Co., Ltd., Healthy Gum
- xanthan gum swelling agent
- Konnyaku Mannan Ina Food Industry Co., Ltd., Mannan 100
- Guar Gum Ina Food Industry Co., Ltd., GR-10
- the composition according to Examples 1 to 20 was obtained by drying with a drum dryer (manufactured by Kashiwagi Seisakusho).
- compositions according to Examples 1 to 20 are powders in a state of being mixed with molecules.
- agar, silium seed gum, xanthan gum, konjac mannan and gum A gum was prepared.
- Example 9 180 130 140
- Example 10 270 170 215 Comparative example 4 286 175 228 [0026] [Table 7]
- the swelling inhibitor alone according to Comparative Examples 1, 3, 5 and 7 has little effect of preventing obesity and improving constipation with a small degree of swelling.
- the swelling agents of Comparative Examples 2, 4, 6 and 8 have a heavy burden on the stomach and intestine when ingested with a high degree of swelling.
- the compositions according to Examples 1 to 20 can obtain a desired degree of swelling by changing the formulation, and can obtain an effect of preventing obesity and an effect of improving constipation appropriate for the person who takes the composition.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006531570A JP4960098B2 (ja) | 2004-08-06 | 2005-08-05 | 膨潤可能な水溶性多糖類からなる膨潤剤が含まれた組成物、並びにその組成物が含まれた食品、肥満防止剤及び便秘改善剤 |
US11/573,298 US20080318897A1 (en) | 2004-08-06 | 2005-08-05 | Composition Containing Swelling Agent Composed of Swellable Water-Soluble Polysaccharide, and Food, Anti-Obesity Agent and Constipation Alleviator Each Containing the Composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-231504 | 2004-08-06 | ||
JP2004231504 | 2004-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006013954A1 true WO2006013954A1 (ja) | 2006-02-09 |
Family
ID=35787232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/014383 WO2006013954A1 (ja) | 2004-08-06 | 2005-08-05 | 膨潤可能な水溶性多糖類からなる膨潤剤が含まれた組成物、並びにその組成物が含まれた食品、肥満防止剤及び便秘改善剤 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20080318897A1 (ja) |
JP (1) | JP4960098B2 (ja) |
CN (1) | CN101022814A (ja) |
WO (1) | WO2006013954A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103461599A (zh) * | 2013-09-24 | 2013-12-25 | 北京绿源求证科技发展有限责任公司 | 一种食疗便秘的养生茶冲剂 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5774072A (en) * | 1980-10-29 | 1982-05-10 | Yamanouchi Pharmaceut Co Ltd | Granule of dietary fiber and its preparation |
JPS62126940A (ja) * | 1985-11-29 | 1987-06-09 | Unie Koroido Kk | 可食性フイルム |
JPH0198460A (ja) * | 1987-10-09 | 1989-04-17 | Fushimi Seiyakushiyo:Kk | 非カロリー性乾燥食品 |
JPH03164149A (ja) * | 1989-11-24 | 1991-07-16 | Masayuki Matsumoto | 乾燥食品の製造方法 |
JPH04207174A (ja) * | 1990-11-30 | 1992-07-29 | Ina Shokuhin Kogyo Kk | 乾物及びその製造方法 |
JPH0515340A (ja) * | 1991-07-10 | 1993-01-26 | Herushii Risubon:Kk | 食物繊維サイリウムの加工方法 |
JPH05153919A (ja) * | 1991-12-04 | 1993-06-22 | Ina Shokuhin Kogyo Kk | 食品具材 |
JPH09224591A (ja) * | 1996-02-20 | 1997-09-02 | Ina Food Ind Co Ltd | 食品具材および食品 |
JP2002209554A (ja) * | 2001-01-18 | 2002-07-30 | Hosoda Shoten:Kk | 栄養補助食品 |
JP2003334027A (ja) * | 2002-05-21 | 2003-11-25 | Noriko Murakami | 寒天含有食品 |
JP2005187442A (ja) * | 2003-12-24 | 2005-07-14 | Kureo Internatl Kk | 便秘及び肥満改善組成物 |
-
2005
- 2005-08-05 US US11/573,298 patent/US20080318897A1/en not_active Abandoned
- 2005-08-05 JP JP2006531570A patent/JP4960098B2/ja not_active Expired - Fee Related
- 2005-08-05 CN CNA2005800265923A patent/CN101022814A/zh active Pending
- 2005-08-05 WO PCT/JP2005/014383 patent/WO2006013954A1/ja active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5774072A (en) * | 1980-10-29 | 1982-05-10 | Yamanouchi Pharmaceut Co Ltd | Granule of dietary fiber and its preparation |
JPS62126940A (ja) * | 1985-11-29 | 1987-06-09 | Unie Koroido Kk | 可食性フイルム |
JPH0198460A (ja) * | 1987-10-09 | 1989-04-17 | Fushimi Seiyakushiyo:Kk | 非カロリー性乾燥食品 |
JPH03164149A (ja) * | 1989-11-24 | 1991-07-16 | Masayuki Matsumoto | 乾燥食品の製造方法 |
JPH04207174A (ja) * | 1990-11-30 | 1992-07-29 | Ina Shokuhin Kogyo Kk | 乾物及びその製造方法 |
JPH0515340A (ja) * | 1991-07-10 | 1993-01-26 | Herushii Risubon:Kk | 食物繊維サイリウムの加工方法 |
JPH05153919A (ja) * | 1991-12-04 | 1993-06-22 | Ina Shokuhin Kogyo Kk | 食品具材 |
JPH09224591A (ja) * | 1996-02-20 | 1997-09-02 | Ina Food Ind Co Ltd | 食品具材および食品 |
JP2002209554A (ja) * | 2001-01-18 | 2002-07-30 | Hosoda Shoten:Kk | 栄養補助食品 |
JP2003334027A (ja) * | 2002-05-21 | 2003-11-25 | Noriko Murakami | 寒天含有食品 |
JP2005187442A (ja) * | 2003-12-24 | 2005-07-14 | Kureo Internatl Kk | 便秘及び肥満改善組成物 |
Non-Patent Citations (1)
Title |
---|
UZUHASHI Y. ET AL: "Kanten no Bussei to Shokuhin eno Oyo", FOODS & FOOD INGRED.J.JAPAN, vol. 208, no. 10, 2003, pages 791 - 800, XP002999397 * |
Also Published As
Publication number | Publication date |
---|---|
JP4960098B2 (ja) | 2012-06-27 |
CN101022814A (zh) | 2007-08-22 |
US20080318897A1 (en) | 2008-12-25 |
JPWO2006013954A1 (ja) | 2008-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Manzoor et al. | Food hydrocolloids: Functional, nutraceutical and novel applications for delivery of bioactive compounds | |
US7067498B2 (en) | Polymer controlled induced viscosity fiber system and uses thereof | |
US8969321B2 (en) | Medical and nutritional applications of highly refined cellulose | |
JP2017537101A (ja) | 食物繊維組成物 | |
JP2010517542A (ja) | アルギン酸塩を含むダイエット食品 | |
CN106901153A (zh) | 圆苞车前子壳粉∕麦麸复合粉及其制备方法 | |
CN105211687A (zh) | 一种组合物及其制备方法与用途 | |
Cakmak et al. | A review on recent advances of plant mucilages and their applications in food industry: Extraction, functional properties and health benefits | |
CN106723087A (zh) | 一种含海带膳食纤维的片剂及其制备方法 | |
JPH06505623A (ja) | ゲル形成液体食物繊維組成物 | |
EP0344116A1 (en) | Easily dispersible psyllium compositions | |
CN112890205A (zh) | 一种减肥组合物及其制备方法 | |
CN106465946A (zh) | 一种润肠通便膳食纤维 | |
JP4960098B2 (ja) | 膨潤可能な水溶性多糖類からなる膨潤剤が含まれた組成物、並びにその組成物が含まれた食品、肥満防止剤及び便秘改善剤 | |
Khan et al. | Nutritional and therapeutic benefits of Psyllium Husk (Plantago ovata) | |
WO2022267788A1 (zh) | 一种魔芋凝胶粉的制备方法及应用 | |
JP2983716B2 (ja) | 水溶性食物繊維コンプレックスを含む食品組成物 | |
WO2010140182A1 (en) | Food compositions comprising flour, glucomannan and a mixture of soluble prebiotic fibres and process for the preparation thereof | |
US20210236537A1 (en) | High porosity cellulosic structures and methods of treatment therewith | |
JP2006129790A (ja) | 食物繊維強化麺類および食物繊維強化麺類の製造方法 | |
JP2014233249A (ja) | 水素発生食品 | |
Madni et al. | Applications of guar gum composites | |
US9023828B2 (en) | Composition comprising at least one alginate for use in treatment and/or prevention of overweight | |
KR101934450B1 (ko) | 새고아미와 하이드로콜로이드(hydrocolloid)를 포함하는 다이어트용 식품 조성물 | |
Lakshmanan | Drug Therapy for Constipation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006531570 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580026592.3 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11573298 Country of ref document: US |